A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.
about
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.[A randomized clinical trial on the clinical efficacy and toxicities of single-agent paclitaxel liposome versus paclitaxel liposome plus oxaliplatin as first-line chemotherapy for advanced non-small cell lung cancer in elderly patients].Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.Nedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancerOxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.Efficacy and safety of docetaxel plus oxaliplatin as a first-line chemotherapy in patients with advanced or metastatic non-small cell lung cancer.A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer.Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy.A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC).Docetaxel and oxaliplatin as first-line therapy for advanced non-small cell lung cancer: a phase II trial.
P2860
Q33366782-5793510A-A86C-437D-8030-1CB60307A39EQ33399713-B1B2B3B5-4077-479D-B613-1B73EFB278E1Q33653575-43620B23-9236-4C92-94FA-2A42B47DF201Q34852774-8E965531-B09B-4B3C-B2A8-8853199C0673Q35858069-75B22995-05A4-4FC3-B4C6-E8E519D3FA66Q36439420-585BF9D1-F259-4460-9A59-5A24B8DEEFA5Q36594055-CC0ED07B-2627-4182-B665-E6A02EBEE3BAQ36623633-17BE2A7C-43BC-4AE3-B212-E53E7DE55CB1Q43849368-8372C578-7ACA-4518-9E14-634568B3856FQ45923820-29BBC34A-F06F-4B82-AB4D-0B02F93B8404
P2860
A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A phase II study of oxaliplati ...... ed non-small-cell lung cancer.
@en
A phase II study of oxaliplati ...... ed non-small-cell lung cancer.
@nl
type
label
A phase II study of oxaliplati ...... ed non-small-cell lung cancer.
@en
A phase II study of oxaliplati ...... ed non-small-cell lung cancer.
@nl
prefLabel
A phase II study of oxaliplati ...... ed non-small-cell lung cancer.
@en
A phase II study of oxaliplati ...... ed non-small-cell lung cancer.
@nl
P2093
P356
P1433
P1476
A phase II study of oxaliplati ...... ced non-small-cell lung cancer
@en
P2093
G A Otterson
J D Winegarden
M A Villalona-Calero
Ohio State University
P C Hoffman
University of Chicago Phase II Network
P304
P356
10.1093/ANNONC/MDH215
P577
2004-06-01T00:00:00Z